PHARNEXT
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Ph... arnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
PHARNEXT
Industry:
Biopharma Biotechnology Medical Neuroscience Pharmaceutical
Founded:
2007-04-01
Address:
Issy-les-moulineaux, Ile-de-France, France
Country:
France
Website Url:
http://www.pharnext.com
Total Employee:
11+
Status:
Active
Contact:
33 1 55 42 62 00
Email Addresses:
[email protected]
Total Funding:
357.81 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Acacia Pharma
Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Boaoxin
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Enimmune
Enimmune is a medical company engaged in the development of drugs through research and studies.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Institute of BioMedical Research
InstituteBMR is a biotech company engaged in the research and manufacture of medical products such as microbicidal agents and disinfectants.
Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Oxford Cannabinoid Technologies
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Quercis Pharma
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Ziphius
Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Truffle Capital
Truffle Capital investment in Venture Round - Pharnext
Parinvest
Parinvest investment in Venture Round - Pharnext
Parinvest
Parinvest investment in Series B - Pharnext
Truffle Capital
Truffle Capital investment in Series B - Pharnext
Financière Boscary
Financière Boscary investment in Series A - Pharnext
Truffle Capital
Truffle Capital investment in Series A - Pharnext
Aurinvest
Aurinvest investment in Series A - Pharnext
Official Site Inspections
http://www.pharnext.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.88 K
- Host name: vps-dfbc05b4.vps.ovh.net
- IP address: 146.59.158.100
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
